NCT05718271

Brief Summary

The goal of this study is to examine if verbal instructions can improve fear extinction learning and extinction retrieval in patients with anxiety disorders (AD) and healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 30, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

February 2, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 14, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 14, 2024

Completed
Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

1.5 years

First QC Date

January 30, 2023

Last Update Submit

September 18, 2024

Conditions

Keywords

anxiety disordersfear extinctionfear conditioninginstructionscontingencies

Outcome Measures

Primary Outcomes (2)

  • Fear extinction learning

    The difference between the reinforced conditioned stimulus (CS+) and non-reinforced conditioned stimulus (CS-) will be measured on 3 different levels: skin conductance responses (SCRs), CS valence ratings ("How pleasant do you feel when you see this picture?"), and UCS expectancy ratings ("Do you think that this picture is paired with an electrical stimulation?").

    Experimental Day 2

  • Extinction retrieval

    The difference between the reinforced conditioned stimulus (CS+) and non-reinforced conditioned stimulus (CS-) will be measured on 3 different levels: skin conductance responses (SCRs), CS valence ratings ("How pleasant do you feel when you see this picture?"), and UCS expectancy ratings ("Do you think that this picture is paired with an electrical stimulation?").

    Experimental Day 3

Secondary Outcomes (2)

  • Fear acquisition

    Experimental Day 1

  • Contingency awareness

    Experimental Day 1

Other Outcomes (3)

  • Score on Intolerance of Uncertainty Scale

    Experimental Day 1

  • Score on General Self-efficacy (GSE) Scale

    Experimental Day 1

  • Trait Anxiety score on State-Trait-Anxiety Inventory

    Experimental Day 1

Study Arms (4)

Explicit instructions before + after extinction

EXPERIMENTAL
Other: Explicit instructions before extinctionOther: Explicit instructions after extinction

Explicit instructions before extinction

EXPERIMENTAL
Other: Explicit instructions before extinction

Explicit instructions after extinction

EXPERIMENTAL
Other: Explicit instructions after extinction

No explicit instructions

NO INTERVENTION

Interventions

"Shocks will no longer be administered during the next phase."

Explicit instructions before + after extinctionExplicit instructions before extinction

"Tomorrow no shocks will be administered."

Explicit instructions after extinctionExplicit instructions before + after extinction

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • For the patient group: DSM-5 anxiety disorder diagnosis via a structured clinical interview for diagnosing mental disorders (DIPS)
  • For the healthy controls: no psychological disorder according to the Mini-DIPS

You may not qualify if:

  • smoking
  • alcohol abuse
  • drug consumption
  • current and chronic physical and neurological diseases
  • for the patient group: anxiety not the primary diagnosis, psychological comorbidities e.g. schizophrenia, bipolar disorder, mental retardation, acute drug or alcohol addiction, personality disorder, currently in psychotherapy
  • for the healthy controls: a diagnosis of psychological disorder at any point in life, ever been in psychotherapy, current and/or regular intake of medicine (incl. psychopharmaceutic medicine), current or past cognitive or neurological disorder
  • for women: pregnancy, nursing period
  • previous experience with fear conditioning paradigm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ruhr University Bochum

Bochum, Germany

Location

Related Publications (1)

  • Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, van den Hout MA, Baas JM. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015 Apr;32(4):239-53. doi: 10.1002/da.22353. Epub 2015 Feb 20.

    PMID: 25703487BACKGROUND

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Armin Zlomuzica, PhD

    Ruhr University Bochum

    PRINCIPAL INVESTIGATOR
  • Marcella L Woud, PhD

    Ruhr University Bochum

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M. Sc.

Study Record Dates

First Submitted

January 30, 2023

First Posted

February 8, 2023

Study Start

February 2, 2023

Primary Completion

August 14, 2024

Study Completion

August 14, 2024

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

This study is carried out within the framework of the German Research Foundation (DFG) funded Collaborative Research Center (SFB) 1280 "Extinction learning". Within the framework of the SFB, almost 20 research groups from Bochum, Essen and Dortmund are working together. Part of the collected data is evaluated jointly. For this purpose, part of the data (e.g. skin conductance, questionnaires) and general information about the person (e.g. gender, age, schooling) are passed on in a pseudonymized form to a central project. Pseudonymized means that the participant's name and date of birth will be replaced by a code and the assignment to the person is only available for employees of this study, but not for employees of the central project.

Locations